Studies have shown that CAIX is a key hypoxia-inducible protein marker, and higher levels of CAIX are associated with poorer survival in patients with TNBC and ovarian, bladder, and lung cancers [45,46]. The gene discussed is CA9; the disease is lung carcinoma.